HeartWorks was created in June 2020 to advance the product development pioneered by the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS), founded at Mayo Clinic in 2010.
HeartWorks has designed a first-of-its-kind platform that brings together physicians, scientists, and engineers to find and develop treatments for the most severe forms of congenital heart defects (CHD) and furthering advanced research in genetics, stem cell biology, clinical trials, and cell-based manufacturing.
We get treatments out of the lab and into clinical trials to be conducted simultaneously in collaboration with a consortium of world-class medical institutions. Our vision is that our therapies will become a cure so children and adults born with CHD will no longer have to live with CHD.
Thank you to our Sponsors
The purpose of HeartWorks’ A Cure is in the Works campaign is to raise money to engage in new clinical trials therefore bringing more research out of the laboratory and into patients.